A brief introductory video explaining Micropore's unique membrane-based system
Our unique technology
Back to Latest News
Micropore has announced the appointment of Camden Cutright as its new Business Development Director based in the US
With a Ph.D. from North Carolina State University, Cam is a chemical engineer whose research background started at Vanderbilt developing photothermally activatable liposomes loaded with chemotherapeutics for localized breast cancer treatment and gold nanoparticles tagged with monoclonal antibodies for prostate cancer diagnostics. From 2016-2020 he was part of a research team led by Dr. Stefano Menegatti and Dr. Jan Genzer at North Carolina State University investigating microgel formulations for molecular separations, sensing, drug delivery, and surface patterning. As Micropore's Business Development Director for the Americas, he will work with clients to develop deliver scalable manufacturing solutions for synthesizing and processing monodisperse, micro- and nano-particles, and API crystals based on our unique membrane-based technology.
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.Ask An Expert
Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.